Abstract Details

<< Back to Detailed Agenda

9/25/2018  |   8:30 AM - 9:30 AM   |  Emerald Ballroom I/II

Discussion Revisited: Is Universal Newborn CMV Screening Good Public Health Policy?

This will be a point-counterpoint panel exploring the pros and cons of universal CMV screening. Each participant will be given 4-5 questions in advance to prepare a one-minute answer. Following each prepared answer, one colleague may make a thirty-second response. The original presenter may respond for 30 sec. (10-15 minutes per question total, 4-5 questions)

  • To understand the reasons for newborn screening for congenital CMV
  • To understand how screening for congenital CMV infection conforms to current guidelines for newborn screening

Presentation:
This presentation has not yet been uploaded.

Handouts:
No handouts have been uploaded.


Pablo Sanchez (Primary Presenter,Author), pablo.sanchez@nationwidechildrens.org;
Dr. Sánchez is a neonatologist and pediatric infectious diseases specialist who has a longstanding interest in clinical and translational research focused on perinatal and neonatal infections and antimicrobial stewardship. He is currently a Professor of Pediatrics, in the Divisions of Neonatology and Pediatric Infectious Diseases and Director of Clinical & Translational Research (Neonatology) in the Center for Perinatal Research at Nationwide Children’s Hospital - The Ohio State University College of Medicine. He earned his medical degree at the University of Pittsburgh School of Medicine in 1981, as well as a fellowship in Neonatal-Perinatal Medicine from Columbia-Presbyterian Medical Center, New York, in 1986 and a fellowship in pediatric infectious disease from the University of Texas Southwestern (UTSW) Medical Center, Dallas, in 1988. He was on faculty at UTSW from 1986 to 2013. Dr. Sánchez is the principal investigator (PI) the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network (NRN) at Nationwide Children’s Hospital – The Ohio State University. Previously, he served in that capacity while at UTSW from 2006-2013. He also served as the Dallas site PI for the National Institutes of Health National Institute on Deafness and Other Communication Disorders CHIMES study on congenital CMV screening and natural history of hearing loss in these infants and children. He has authored and co-authored more than 100 peer-reviewed publications and book chapters.

      ASHA DISCLOSURE:

Financial - Receives Grants,Other financial benefit for Membership on advisory committee or review panels from MedImmune/AstraZeneca.   Receives Grants for Other activities from Merck.   Receives Other financial benefit for Membership on advisory committee or review panels from Sanofi-Pasteur.  

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - Receives support from Medimmune-AstraZeneca Sanofi Pasteur Merck.  




Sheila Dollard (Co-Presenter), sgd5@cdc.gov;
Sheila Dollard earned her PhD in Biochemistry in 1991 from the University of Rochester Medical Center, Rochester. Her research focused on gene transcription and tissue specificity of human papillomaviruses. From 1992-1995 she was a post-doctoral fellow studying HIV gene transcription and pathogenesis in the Department of Microbiology at the University of Rochester. From 1995-1997 she served as Instructor and Fellow in the Residency Program in Public Health Laboratory Microbiology at Strong Memorial Hospital. In 1998 Dr. Dollard joined the Centers for Disease Control and Prevention as Team Leader for Herpesvirus Diagnostic Development where her work has focused on HHV-8 (human herpesvirus 8) and CMV epidemiology and diagnostics for the past 16 years. Dr. Dollard has been a co-Investigator on numerous NIH grants for HHV-8 and CMV. She has authored and co-authored over 60 papers in peer-reviewed journals and has co-authored 4 book chapters for HHV-8 and CMV.

      ASHA DISCLOSURE:

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - Receives support from Centers for Disease Control and Prevention.  




Kirstin Coverstone (Co-Presenter), kristin.coverstone@umn.edu;
Kirsten Coverstone is an audiologist with many years of service dedicated to early hearing detection and intervention. She grew up in southern Minnesota, earned her masters degree from the Univ. of Northern Iowa and her doctorate from Salus University. Kirsten has actively worked at the local state and national levels to promote universal newborn screening for hearing. As coordinator of the Lions Infant Hearing Program at the University of Minnesota she worked directly with hospitals to establish effective hearing screening programs and audiologists to confirm hearing loss. In addition, Kirsten implemented a statewide hearing instrument loaner program for infants and young children in Minnesota. She is dedicated to making a difference in the lives of children and their families as the MDH EHDI Screening Program Coordinator.

      ASHA DISCLOSURE:

Financial -

Nonfinancial -


      AAA DISCLOSURE:

Financial - No relevant financial relationship exists.




Fatima Kakkar (Co-Presenter), fatima.kakkar@umontreal.ca;
Fatima Kakkar is a Paediatric infectious diseases specialist and clinician researcher at the University of Montreal, Sainte-Justine Hospital Center, and chair of the Canadian Paediatric and Perinatal AIDS research group. Her interests have expanded recently from paediatric HIV to other congenital infections, and specifically cCMV infection.

      ASHA DISCLOSURE:

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - No relevant financial relationship exists.